DefiPace to help prevent heart rhythm problems after heart surgery
Part of Heart & circulation clinical trials.
This study tests DefiPace in people who are having planned open-chest heart surgery (bypass and/or valve surgery) to see if it can help reduce certain post-surgery heart rhythm complications. Whether it’s usable depends on your planned procedure and specific health factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and having planned open-chest heart surgery (bypass and/or valve surgery)
- If you’re having only bypass surgery, you must be at least 70; if you’re having valve surgery, at least 60
- Your doctor must be able to get your written consent before the operation
- You must be scheduled for the specific DefiPace-related step during the surgery (called TMA implantation) if the study phase applies to you
- You should not have a history of atrial fibrillation (lasting or coming and going)
- You must not have certain heart device implants or have had recent stroke (within 3 months), endocarditis, or be pregnant at the time of surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether an added heart device approach around the time of planned open-heart surgery can help treat non-paroxysmal atrial fibrillation (AF), a long-lasting irregular heartbeat. It may help lower ongoing AF burden in people who also need non-emergency heart surgery.
This trial tests a new device used during open-heart surgery to treat atrial fibrillation (AFib) by delivering tiny, fast electrical pulses to the heart tissue. It is for people who are already having heart surgery and want to also treat their AFib at the same time.
This trial studies whether giving a medication (amiodarone) during and after certain heart surgeries can help prevent atrial fibrillation, an irregular heartbeat that can happen after surgery. It may help by aiming to stop this rhythm problem before it starts.
This trial tests a new type of pacemaker for people with atrial fibrillation who are scheduled for a procedure that disconnects the heart's natural electrical pathway. It may help improve symptoms and heart function.
This trial tests if giving the medication amiodarone before and after heart surgery can prevent a common complication called atrial fibrillation (an irregular heartbeat). It is for people who do not already have atrial fibrillation and are having heart surgery that is not coronary artery bypass.
This trial studies whether a short course of amiodarone started right after heart surgery can reduce problems from new-onset atrial fibrillation (a common fast heart rhythm) or flutter. It may help some patients avoid ongoing rhythm issues and improve recovery soon after discharge.
Hear when a new Post-operative Atrial Fibrillation POAF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.